| Pastori D, Esposito A, Cagliuso M, et al.
Lithiasis of semicircular canals and parotid glands: unusual stones deposition in atazanavir-treated individuals. [Letter]
AIDS 2009 Oct 23; 23(16):2233-4.
Full Citation | Publisher Full Text | Find Related Articles |
| Hill A, Sawyer W
Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients. [Journal Article]
HIV Med 2009 Oct; 10(9):527-35.
Abstract | Full Citation | Find Related Articles |
| Izzedine H, Harris M, Perazella MA
The nephrotoxic effects of HAART. [Journal Article]
Nat Rev Nephrol 2009 Oct; 5(10):563-73.
Abstract | Full Citation | Find Related Articles |
| [In Process Citation] [Journal Article]
MMW Fortschr Med 2009 Apr 30; 151(18):35.
Full Citation |
| Hsieh SM, Chang SY, Hung CC, et al.
Impact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure. [JOURNAL ARTICLE]
BMC Infect Dis 2009 Sep 14; 9(1):154.
Abstract | Full Citation | Find Related Articles |
| Tozzi V
Pharmacogenetics of antiretrovirals. [JOURNAL ARTICLE]
Antiviral Res 2009 Sep 7.
Abstract | Full Citation | Find Related Articles |
| Calza L, Manfredi R, Colangeli V, et al.
Efficacy and safety of atazanavir-ritonavir plus abacavir-lamivudine or tenofovir-emtricitabine in patients with hyperlipidaemia switched from a stable protease inhibitor-based regimen including one thymidine analogue. [Journal Article]
AIDS Patient Care STDS 2009 Sep; 23(9):691-7.
Abstract | Full Citation | Find Related Articles |
| Chetchotisakd P
The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients. [Journal Article]
Expert Rev Anti Infect Ther 2009 Sep; 7(7):801-5.
Abstract | Full Citation |
| Tozzi V, Balestra P, Salvatori MF, et al.
Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. [Journal Article, Research Support, Non-U.S. Gov't]
J Acquir Immune Defic Syndr 2009 Sep 1; 52(1):56-63.
Abstract | Full Citation |
| Pérez-Elías MJ, Gatell JM, Flores J, et al.
Short-Term Effect of Ritonavir-Boosted Atazanavir in Hepatitis B and/or C Co-infected, Treatment-Experienced HIV Patients. [Journal Article]
HIV Clin Trials 2009 Jul-Aug; 10(4):269-75.
Abstract | Full Citation | Find Related Articles |
   |
